Trial intelligence / Profile preview

IV Iron Supplementation with Darbepoetin Alfa for Chemo-Induced Anemia

NCT00210002Phase 2Terminated

Sponsor
Institut Claudius Regaud
Start
Nov 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of iron sucrose, sponsored by Institut Claudius Regaud. Started Nov 2003; status: terminated.

02

Drugs

iron sucrose

Beyond the preview

Go deeper on NCT00210002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00210002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call